Audronyte Egle, Sutnikiene Vaiva, Pakulaite-Kazliene Gyte, Kaubrys Gintaras
Clinic of Neurology and Neurosurgery, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania.
Front Neurol. 2023 Jun 2;14:1165594. doi: 10.3389/fneur.2023.1165594. eCollection 2023.
Olfaction is impaired in Alzheimer's disease (AD). However, olfactory memory has rarely been examined. As the pathogenesis of AD remains largely unknown, collecting more data regarding the occurrence and progression of its symptoms would help gain more insight into the disease.
To investigate olfactory memory and its relationship with verbal memory and other clinical features in patients with early-stage AD.
Three groups of participants were enrolled in this study: patients with mild dementia due to AD (MD-AD, = 30), patients with mild cognitive impairment due to AD (MCI-AD, = 30), and cognitively normal older participants (CN, = 30). All participants underwent cognitive evaluation (Clinical Dementia Rating scale, Mini Mental State Examination, Alzheimer's Disease Assessment Scale-Cognitive Subscale, delayed verbal recall, and verbal fluency tests) and assessment of olfactory immediate and delayed recognition memory.
Olfactory immediate and delayed recognition memory scores were significantly lower in the MD-AD group than in the MCI-AD and CN groups. The MCI-AD and CN groups did not differ significantly [in both cases, Kruskal-Wallis test, < 0.05; analysis revealed significant differences between the MD-AD and MCI-AD groups and between the MD-AD and CN groups ( < 0.05), and no significant difference between the MCI-AD and CN groups ( > 0.05)]. Verbal immediate recall, delayed recall after 5 min, and delayed recall after 30 min scores were significantly worse in the MD-AD and MCI-AD groups than in the CN group. MD-AD and MCI-AD groups did not differ significantly [in all cases Kruskal-Wallis test, < 0.05; analysis revealed significant differences between MD-AD and CN groups, and MCI-AD and CN groups ( < 0.05) and no significant difference between MD-AD and MCI-AD groups ( > 0.05)]. Duration of AD symptoms was a strong predictor of both immediate and delayed olfactory recognition memory scores.
Olfactory memory impairment was observed in patients with AD. The changes progress during the course of the disease. However, unlike verbal memory, olfactory memory is not significantly impaired in the prodromal stage of AD.
阿尔茨海默病(AD)患者存在嗅觉障碍。然而,嗅觉记忆很少被研究。由于AD的发病机制在很大程度上仍不清楚,收集更多关于其症状发生和进展的数据将有助于更深入地了解该疾病。
研究早期AD患者的嗅觉记忆及其与言语记忆和其他临床特征的关系。
本研究招募了三组参与者:AD所致轻度痴呆患者(MD-AD,n = 30)、AD所致轻度认知障碍患者(MCI-AD,n = 30)和认知正常的老年参与者(CN,n = 30)。所有参与者均接受了认知评估(临床痴呆评定量表、简易精神状态检查、阿尔茨海默病评估量表-认知分量表、延迟言语回忆和言语流畅性测试)以及嗅觉即刻和延迟识别记忆评估。
MD-AD组的嗅觉即刻和延迟识别记忆得分显著低于MCI-AD组和CN组。MCI-AD组和CN组之间无显著差异[两种情况均采用Kruskal-Wallis检验,P < 0.05;事后分析显示MD-AD组与MCI-AD组之间以及MD-AD组与CN组之间存在显著差异(P < 0.05),而MCI-AD组与CN组之间无显著差异(P > 0.05)]。MD-AD组和MCI-AD组的言语即刻回忆、5分钟后延迟回忆和30分钟后延迟回忆得分均显著低于CN组。MD-AD组和MCI-AD组之间无显著差异[所有情况均采用Kruskal-Wallis检验,P < 0.05;事后分析显示MD-AD组与CN组之间以及MCI-AD组与CN组之间存在显著差异(P < 0.05),而MD-AD组与MCI-AD组之间无显著差异(P > 0.05)]。AD症状持续时间是嗅觉即刻和延迟识别记忆得分的有力预测指标。
AD患者存在嗅觉记忆障碍。这些变化在疾病过程中进展。然而,与言语记忆不同,AD前驱期嗅觉记忆无显著受损。